Product Information
ADAPALENE-BNZYL PEROX 0.3-2.5% is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.6260 per GM under NDC 51672138409. Its NADAC has been published 229 times since May 18, 2022.
FDA first approved this application on Oct 17, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3; 25 mg/g; mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672138409
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
ADAPALENE; BENZOYL PEROXIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209148FDA Approved
10/17/2018
TE Code
AB
On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for ADAPALENE-BNZYL PEROX 0.3-2.5% has been published 229 times since May 18, 2022, and over the history we have for it it has declined 94.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6260 per GM |
|---|---|
| All-time high | $10.3827 (Jun 15, 2022) |
| All-time low | $0.5830 (Nov 20, 2024) |
| 52-week high | $0.7063 |
| 52-week low | $0.5996 |
| Median price | $0.7158 |
| Average price | $1.6163 |
| Largest weekly change | +75.1% (Aug 23, 2023) |
| Weeks tracked | 229 |
| Tracking since | May 18, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ADAPALENE and BENZOYL PEROXIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ADAPALENE and BENZOYL PEROXIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADAPALENE-BNZYL PEROX 0.3-2.5%?
The current National Average Drug Acquisition Cost (NADAC) for ADAPALENE-BNZYL PEROX 0.3-2.5%, manufactured by Sun Pharmaceutical Industries Inc., is $0.6260 per GM (NDC 51672138409), effective Sep 30, 2026.
How has the price of ADAPALENE-BNZYL PEROX 0.3-2.5% changed over time?
Over the history we have for it, the NADAC for ADAPALENE-BNZYL PEROX 0.3-2.5% has declined 94.0%. It has been tracked across 229 weekly CMS publications since May 18, 2022.
What are the highest and lowest recorded NADAC prices for ADAPALENE-BNZYL PEROX 0.3-2.5%?
Since May 18, 2022, the NADAC for ADAPALENE-BNZYL PEROX 0.3-2.5% has ranged from a low of $0.5830 (Nov 20, 2024) to a high of $10.3827 (Jun 15, 2022), with a median of $0.7158 per GM.
Are there cheaper alternatives to ADAPALENE-BNZYL PEROX 0.3-2.5%?
No other NADAC-published product currently shares the active ingredient and strength of ADAPALENE-BNZYL PEROX 0.3-2.5% in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ADAPALENE-BNZYL PEROX 0.3-2.5%?
ADAPALENE-BNZYL PEROX 0.3-2.5% (NDC 51672138409) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.